Congo vs Norway: Previously treated cases tested for RR-/MDR-TB
Congo
100.0%
in 2024
Norway
100.0%
in 2024
Congo rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Congo
- Norway
How they compare
Congo currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 4 times across 11 shared years of data; in 2013 it was Norway ahead.
Congo ranks 1st and Norway ranks 1st of 180 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Norway in 1.
Head to head by decade
| Decade | Congo | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 57.2% | 20.0% | Congo |
| 2020s | 69.8% | 89.4% | 19.6% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Congo or Norway?
- Congo, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Congo and Norway?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Norway?
- 11 years are reported by both, from 2013 to 2024.
- How do Congo and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Congo ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.